John McCafferty,
Founder & CEO,
IONTAS Ltd
Pioneer and inventor of antibody-phage display and co-founder of Cambridge Antibody Technology. John established a highly proficient proteomics group at the Wellcome Trust Sanger Institute which developed cutting edge protein expression and high throughput recombinant antibody isolation.
More recently he has headed a research group within the Department of Biochemistry, University of Cambridge. The focus here was identifying anti-receptor antibodies with therapeutic potential in cancer indications.
In 2012 John formed IONTAS, a small innovative biotechnology company using phage display to develop novel antibody therapeutics. In addition IONTAS are developing novel technologies allowing discovery of IgG formatted antibodies directly from very large mammalian display libraries.
|
|
|
Add to Calendar ▼2016-02-09 09:00:002016-02-09 10:00:00Europe/LondonConstruction and Use of Large Antibody Libraries in Mammalian Cells Antibodies in Drug Discovery in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com
